Pax Fund Inc. – Trademark Portfolio
Entity Type: 03
Pax Fund Inc. holds 12 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 6 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 3 Nice Classification classes. Currently, 5 trademarks are registered and 1 is pending. Notable registered marks include ECOEARS, ECOEATS, ECOSPOT, and VET ORGANICS. The owner is based in BOCA RATON, FL.
6317 HOLLANDAIRE DR. E.
BOCA RATON, FL 33433
Showing of trademarks Trademarks
Trademark Classifications
Pax Fund Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Raw and unprocessed agricultural, aquacultural, horticultural and forestry products
Frequently Asked Questions
How many trademarks does Pax Fund Inc. have?
Pax Fund Inc. has 12 U.S. trademarks filed with the USPTO. Of these, 5 registered, 1 pending, 1 abandoned, 5 cancelled.
What trademark classes does Pax Fund Inc. file in?
Pax Fund Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning), Class 31 (Natural Agricultural Products). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Pax Fund Inc.'s most well-known trademarks?
Pax Fund Inc.'s registered trademark portfolio includes well-known marks such as ECOEARS, ECOEATS, ECOSPOT, and VET ORGANICS. These are among 5 currently registered trademarks in the portfolio.
What is Pax Fund Inc.'s trademark registration success rate?
Pax Fund Inc. has a 45% trademark registration rate, with 5 out of 11 resolved applications resulting in successful registration. Currently, 1 application is pending review.